boston pharma LLC

3440 boston road
bronx, new york 10469

NYS Entity Status
ACTIVE

NYS Filing Date
DECEMBER 23, 2013

NYS DOS ID#
4504402

County
BRONX

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - BOSTON PHARMA LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Checkmate Pharma Clinches $27M for More Studies in Skin Cancer
    By Frank Vinluan - Thursday Jun 15, 2017

    Checkmate Pharmaceuticals believes its approach to cancer treatment can make a certain type of immunotherapy work better, and it now has $27 million in additional funding to help build that case. F-Prime Capital Partners, a new investor, led the Series B round of investment announced Thursday. Sofinnova Partners and venBio, who had invested in Cambridge, […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
    By LIAM STACK - Monday Jun 19, 2017

    The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.

    Source: NYT > Home Page
  • Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal
    By Ben Fidler - Monday Jun 12, 2017

    Dragonfly Therapeutics, a stealthy startup formed by well-known cancer researchers on both coasts and backed by a high-powered group of family offices, has inked its first partnership. Celgene, of Summit, NJ, is paying Dragonfly $33 million up front for the chance to co-develop up to four blood cancer drugs. The deal is a modest bet […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal
    By Ben Fidler - Monday Jun 12, 2017

    Dragonfly Therapeutics, a stealthy startup formed by well-known cancer researchers on both coasts and backed by a high-powered group of family offices, has inked its first partnership. Celgene, of Summit, NJ, is paying Dragonfly $33 million up front for the chance to co-develop up to four blood cancer drugs. The deal is a modest bet […]

    Source: Xconomy New York
  • Bio Roundup: Trumpcare is Mean, SCOTUS Says Go, Merck’s Myeloma No
    By Ben Fidler - Friday Jun 16, 2017

    What exactly does the American Health Care Act, the Republican proposal to replace Obamacare, currently look like? Few people know, because the Senate version is being negotiated behind closed doors in Washington D.C. without any public hearings. We do know President Trump now thinks the version of the AHCA that squeaked through the House is […]

    Source: Xconomy New York
  • Bio Roundup: Trumpcare is Mean, SCOTUS Says Go, Merck’s Myeloma No
    By Ben Fidler - Friday Jun 16, 2017

    What exactly does the American Health Care Act, the Republican proposal to replace Obamacare, currently look like? Few people know, because the Senate version is being negotiated behind closed doors in Washington D.C. without any public hearings. We do know President Trump now thinks the version of the AHCA that squeaked through the House is […]

    Source: Xconomy VC, Deals, & Startups Feed
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • Bio Roundup: ASCO Digested, Juliet Unveiled, PTC Slated & More
    By Alex Lash - Friday Jun 9, 2017

    The New York Times Magazine wrote a few weeks ago about the extraordinary metabolic changes in a python after it gulps down a 50,000 calorie meal. The biomedical world was like a postprandial python this week; after extending its maw around the supersized meal of news and data from the American Society for Clinical Oncology […]

    Source: Xconomy New York